Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Annatina Schnegg-Kaufmann"'
Autor:
Julie A.I. Thoms, Annatina Schnegg-Kaufmann, Golam Sarower Bhuyan, Henry R. Hampton, Lachlin Vaughan, Kayleigh Rutherford, Purvi M. Kakadia, Hui Mei Lee, Emma Johansson, Tim W. Failes, Greg M. Arndt, Jason Koval, Sarah Davidson, Robert Lindeman, Pauline Warburton, Alba Rodriguez-Meira, Adam J Mead, Ashwin Unnikrishnan, Mark Hertzberg, Mark N. Polizzotto, Elli Papaemmanuil, Stefan K. Bohlander, Omid Faridani, Christopher J. Jolly, Fabio Zanini, John E. Pimanda
Publikováno v:
Blood. 140:9751-9752
Autor:
Annatina Schnegg-Kaufmann, Julie A. I. Thoms, Golam Sarower Bhuyan, Henry R. Hampton, Lachlin Vaughan, Kayleigh Rutherford, Purvi M. Kakadia, Emma M. V. Johansson, Tim Failes, Greg M. Arndt, Jason Koval, Robert Lindeman, Pauline Warburton, Alba Rodriguez-Meira, Adam J. Mead, Ashwin Unnikrishnan, Stefan K. Bohlander, Elli Papaemmanuil, Omid Faridani, Christopher J. Jolly, Fabio Zanini, John E. Pimanda
Progressively acquired somatic mutations in hematopoietic stem cells are central to pathogenesis in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). They can lead to proliferative advantages, impaired differentiation and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbcc319bfd3ab113a7e7e2f88732a8b8
https://doi.org/10.1101/2022.01.20.476890
https://doi.org/10.1101/2022.01.20.476890
Autor:
Nicolas Bonadies, Kristina Stojkov, Helena Simeunovic, Ioannis Chanias, Ulrike Bacher, Alicia Rovó, Georg Stuessi, Gregor Stehle, Annatina Schnegg-Kaufmann, Stefan Balabanov, Axel Ruefer, Ramanjaneyulu Allam, Linet M. Njue, Michael Daskalakis, Rudolf Benz, Adrian Schmidt, Marcel Adler, Naomi Porret, Tata Nageswara Rao
Publikováno v:
Cancers
Cancers, Vol 13, Iss 3296, p 3296 (2021)
Chanias, Ioannis; Stojkov, Kristina; Stehle, Gregor Th.; Daskalakis, Michael; Simeunovic, Helena; Njue, Linet Muthoni; Schnegg-Kaufmann, Annatina S.; Porret, Naomi A.; Allam, Ramanjaneyulu; Tata, Nageswara Rao; Benz, Rudolf; Ruefer, Axel; Schmidt, Adrian; Adler, Marcel; Rovo, Alicia; Balabanov, Stefan; Stuessi, Georg; Bacher, Ulrike; Bonadies, Nicolas (2021). Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine. Cancers, 13(13) MDPI AG 10.3390/cancers13133296
Cancers, Vol 13, Iss 3296, p 3296 (2021)
Chanias, Ioannis; Stojkov, Kristina; Stehle, Gregor Th.; Daskalakis, Michael; Simeunovic, Helena; Njue, Linet Muthoni; Schnegg-Kaufmann, Annatina S.; Porret, Naomi A.; Allam, Ramanjaneyulu; Tata, Nageswara Rao; Benz, Rudolf; Ruefer, Axel; Schmidt, Adrian; Adler, Marcel; Rovo, Alicia; Balabanov, Stefan; Stuessi, Georg; Bacher, Ulrike; Bonadies, Nicolas (2021). Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine. Cancers, 13(13) MDPI AG 10.3390/cancers13133296
Simple Summary With demographic ageing, improved cancer survivorship and increased diagnostic sensitivity, incident cases of patients with Myelodysplastic Syndromes (MDS) are continuously rising, leading to a relevant impact on health care resources.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fbf995eaefba52948ea69211a04929c
https://www.zora.uzh.ch/id/eprint/207120/
https://www.zora.uzh.ch/id/eprint/207120/
Autor:
Sonia Benzarti, Georg Stussi, Nicolas Bonadies, Rudolf Benz, Max Solenthaler, Anita Feller, Volker Arndt, Michael Daskalakis, Andreas Holbro, Annatina Schnegg-Kaufmann, Vera Ulrike Bacher, Adrian Schmidt, Axel Rüfer
Publikováno v:
Cancer Epidemiology. 59:51-57
Chronic myelomonocytic leukemia (CMML) is a rare hematopoietic malignancy. Treatment with hypomethylating agents (HMA) was introduced between 2004 and 2006 but its impact on population-based survival remains controversial. The aim of this study was t
Autor:
Markus Aschwanden, Joseph Osterwalder, Lucia Mazzolai, Anne Angelillo-Scherrer, Nils Kucher, Oliver Hugli, Daniel Staub, Marc Husmann, Juerg-Hans Beer, Beat Frauchiger, Michael Nagler, Marie Méan, Sara Calzavarini, Annatina Schnegg-Kaufmann, Drahomir Aujesky, Martin Banyai, Michael Daskalakis, Andreas Limacher, Christian M. Matter, Marc Philip Righini, Nicolas Rodondi
Publikováno v:
Journal of Thrombosis and Haemostasis
Journal of thrombosis and haemostasis, vol. 17, no. 2, pp. 306-318
Journal of Thrombosis and Haemostasis, Vol. 17, No 2 (2019) pp. 306-318
Journal of thrombosis and haemostasis, vol. 17, no. 2, pp. 306-318
Journal of Thrombosis and Haemostasis, Vol. 17, No 2 (2019) pp. 306-318
Essentials Predictive ability of pro-hemostatic Gas6 for recurrent venous thromboembolism (VTE) is unknown. We measured Gas6 levels in 864 patients with VTE over 3 years. High Gas6 (> 157%) at diagnosis is associated with VTE recurrence, major bleedi
Autor:
Anita Feller, Nicolas Bonadies, Mario Bargetzi, Yves Chalandon, Volker Arndt, Annatina Schnegg-Kaufmann, Alicia Rovó, Georg Stussi, Michael Gregor, Jakob Passweg, Markus G. Manz, Helen Baldomero, Urs Hess, Anna Efthymiou, Olivier Spertini
Publikováno v:
Cancer Epidemiology, Vol. 52 (2018) pp. 55-62
Acute Myeloid Leukaemia (AML) is a rare and heterogeneous haematological malignancy with increasing incidence in the elderly. We performed a population-based, observational analysis of AML cases reported to the Cantonal Cancer Registries in Switzerla
Autor:
Jakob Passweg, Georg Stuessi, Urs Hess, Alicia Rovó, Anna Efthymiou, Olivier Spertini, Nicolas Bonadies, Volker Arndt, Yves Chalandon, Markus G. Manz, Mario Bargetzi, Annatina Schnegg-Kaufmann, Anita Feller, Helen Boldomero, Michael Gregor
Publikováno v:
Blood. 130:863-863
Introduction: Acute Myeloid Leukaemia (AML) is a rare disease with increasing frequency in the elderly and an emerging impact on health care resources. Trends of classification, incidence, mortality, and survival of AML patients have not yet been rep